SURMODICS INC — Director's Dealing 2020

Feb 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2020-02-20

Reporting Person: BEDOYA JOSE H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-20	Common Stock	S	1821	$37.5147	Disposed	21750	Direct

Footnotes

F1: Reflects the weighted average price of 1,821 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 20, 2020 with sale prices ranging from $37.51 to $37.55 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The amount beneficially owned includes 10,995 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.